Tollys Alternatives & Competitors
5 companies similar to Tollys — A new dimension in immuno-oncology
Companies similar to Tollys
GrayBug
Saving Sight Through Transformative Science.
Redwood City, United Stat...
Manchester, United Kingdo...
France
Kojin Therapeutics
Developing transformative medicines based on a groundbreaking approach to ferroptosis and...
Boston, United States
Rival Readout
Competing with Tollys? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Geen
A platform designed for prototyping genetic engineering concepts.
Istanbul, Turkey
About Tollys
TOLLYS, founded in 2015 in France, is carving a niche in the immuno-oncology landscape with its groundbreaking work on specific TLR3 agonists. Emerging from leading European cancer research hubs, TOLLYS is addressing a significant gap by focusing on homogeneous TLR3 agonists critical for inducing tumor cell death and e...
casino games, sports betting, live gaming
gambling enthusiasts, casino players, online bettors
Immuno-oncology, TLR3 Agonists, Tumor Cell Death, Immunostimulant Properties, Tumoral Micro-environment, Cytotoxic T Lymphocytes, Anti-tumor Effects, In-situ Auto Vaccination, DsRNA, TL-532, Immune Checkpoint Inhibitors, Non Muscle Invasive Bladder Cancer, BCG Treatment, Innate Immunity, Synthetic RNA
B2B, B2D
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tollys: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tollys on 17 Sep 2025. The 5 companies listed here were last checked between 23 Nov 2025 and 20 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
